Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

23.62
-0.4900-2.03%
Post-market: 23.620.00000.00%16:05 EDT
Volume:4.21M
Turnover:100.13M
Market Cap:17.42B
PE:-76.19
High:24.54
Open:23.70
Low:23.20
Close:24.11
Loading ...

Stock Track | Summit Therapeutics' Stock Plummets 5.04% on Disappointing Ivonescimab Trial Updates

Stock Track
·
25 Feb

Summit Incurs In-Line Q4 Loss, Inks Collaboration Deal With Pfizer

Zacks
·
25 Feb

Q4 2024 Summit Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
25 Feb

Summit Therapeutics Inc (SMMT) Q4 2024 Earnings Call Highlights: Strong Financial Position and ...

GuruFocus.com
·
25 Feb

BUZZ-Summit Therapeutics falls on wider Q4 loss, deal expectations from investors

Reuters
·
25 Feb

Top Midday Decliners

MT Newswires Live
·
25 Feb

Sector Update: Health Care Stocks Gain Monday Afternoon

MT Newswires Live
·
25 Feb

Is Summit Therapeutics (SMMT) One of the Best Growth Stocks to Invest In According to Analysts?

Insider Monkey
·
25 Feb

BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities

Reuters
·
24 Feb

Summit Therapeutics Shares Down as 4Q Loss Widens

Dow Jones
·
24 Feb

Stock Track | Summit Therapeutics Stock Plunges 5.02% on Monday Amid Clinical Trial Collaboration News

Stock Track
·
24 Feb

Summit Therapeutics Shares Reverse Course From Premarket Gains; Last Down 8.7%

THOMSON REUTERS
·
24 Feb

BUZZ-U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop

Reuters
·
24 Feb

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday

MT Newswires Live
·
24 Feb

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Investors Focus on Inflation Data

MT Newswires Live
·
24 Feb

BUZZ-U.S. STOCKS ON THE MOVE-Nike, Domino's Pizza, Apple

Reuters
·
24 Feb

Summit Therapeutics Partners With Pfizer to Test Cancer Drug Combinations

MT Newswires Live
·
24 Feb

BRIEF-Summit Therapeutics Collaborates With Pfizer To Evaluate Ivonescimab Trial

Reuters
·
24 Feb

Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos

Dow Jones
·
24 Feb

BUZZ-Summit Therapeutics rises on clinical trial collaboration with Pfizer

Reuters
·
24 Feb